These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33471702)

  • 21. Sex Differences in Hypercortisolism and Glucose-Metabolism Disturbances in Patients with Mild Autonomous Cortisol Secretion: Findings From a Single Center in China.
    Ouyang R; Yin Y; Wang J; Su W; Zang L; Chen K; Du J; Lyu Z; Dou J; Mu Y; Gu W
    Front Endocrinol (Lausanne); 2022; 13():857947. PubMed ID: 35757395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.
    Tsagarakis S; Vassiliadi D; Thalassinos N
    J Endocrinol Invest; 2006 May; 29(5):471-82. PubMed ID: 16794373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?
    Cansu GB; Atılgan S; Balcı MK; Sarı R; Özdem S; Altunbaş HA
    Hormones (Athens); 2017 Jan; 16(1):22-32. PubMed ID: 28500825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study.
    Zavatta G; Vicennati V; Altieri P; Tucci L; Colombin G; Coscia K; Mosconi C; Balacchi C; Fanelli F; Malagrinò M; Magagnoli M; Golfieri R; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2023 Apr; 188(4):343-352. PubMed ID: 36952249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
    Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
    J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
    Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
    Belokovskaya R; Ravikumar A; Arumugam D; Izadmehr S; Goddard GM; Geer EB; Levine AC
    Endocr Pract; 2019 Aug; 25(8):846-853. PubMed ID: 31070948
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of Body Composition in Patients With and Without Adrenal Tumors and Without Overt Hypersecretory Syndromes.
    Araujo-Castro M; Pascual-Corrales E; García Cano AM; Marchan M; Casals G; Hanzu FA; Gomez-Bermejo MÁ; Escobar Morreale HF; Valderrabano P
    Endocr Pract; 2023 Feb; 29(2):110-118. PubMed ID: 36455692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: The cause-effect relationship?
    Marina LV; Ivović M; Tančić-Gajić M; Arizanović Z; Raković D; Milin-Lazović J; Kendereški A; Micić D; Vujović S
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):541-548. PubMed ID: 29288564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
    de Paula MP; Moraes AB; de Souza MDGC; Cavalari EMR; Campbell RC; Fernandes GDS; Farias MLF; Mendonça LMC; Madeira M; Bouskela E; Kraemer-Aguiar LG; Vieira Neto L
    J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone-nonsuppressible cortisol in two cases with aldosterone-producing adenoma.
    Imai T; Seo H; Murata Y; Funahashi H; Satoh Y; Sasano H; Matsui N; Takagi H
    J Clin Endocrinol Metab; 1991 Mar; 72(3):575-81. PubMed ID: 1997511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
    Arruda M; Mello Ribeiro Cavalari E; Pessoa de Paula M; Fernandes Cordeiro de Morais F; Furtado Bilro G; Alves Coelho MC; de Oliveira E Silva de Morais NA; Choeri D; Moraes A; Vieira Neto L
    J Hum Hypertens; 2017 Dec; 32(1):3-11. PubMed ID: 29176595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
    Araujo-Castro M; Casals G; Hanzu FA; Pascual-Corrales E; García Cano AM; Lanza VF; Luis Del Rey Mejías Á; Marchan M; Escobar-Morreale HF; Valderrabano P
    Clin Endocrinol (Oxf); 2023 Feb; 98(2):165-176. PubMed ID: 35973974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical shift magnetic resonance imaging could predict subclinical cortisol production from an incidentally discovered adrenal mass.
    Yener S; Secil M; Demir O; Ozgen Saydam B; Yorukoglu K
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):779-786. PubMed ID: 29498083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.